Immunoglobulin Case
Criminal misappropriation and related offences over the procurement and distribution of substandard IVIG (and Rituximab), using forged/irregular documents; alleged loss around Rs. 144.4 million. Alleged procurement of substandard Human Immunoglobulin (IVIG) and related supplies using forged/irregular documents, causing public loss and risk to patients. Arrests in 2024 WHO-approved lab results in June 2025 supported contamination findings Attorney General filed a 13-count indictment on 2025-06-26.
Allegations
Criminal misappropriation of public funds via irregular IVIG procurement, Use of forged documents to import unregistered medical products, Distribution of substandard/contaminated IVIG causing public risk
Timeline
Timeline of Events
🖱 Scroll to zoom | Drag to move | Hold Ctrl + scroll for fine zoom